Validated using a knockout cell line

Anti-Met (c-Met) antibody [EP1454Y] (ab51067)

Publishing research using ab51067? Please let us know so that we can cite the reference in this datasheet.

ab51067 has been referenced in 22 publications.

  • Cho SH  et al. The Antitumor Effect of C-terminus of Hsp70-Interacting Protein via Degradation of c-Met in Small Cell Lung Cancer. Korean J Thorac Cardiovasc Surg 50:153-162 (2017). PubMed: 28593150
  • Wang H  et al. DCLK1 is correlated with MET and ERK5 expression, and associated with prognosis in malignant pleural mesothelioma. Int J Oncol 51:91-103 (2017). PubMed: 28560410
  • Xie C  et al. Expression of c-Met and hepatocyte growth factor in various gastric pathologies and its association withHelicobacter pyloriinfection. Oncol Lett 14:6151-6155 (2017). PubMed: 29113260
  • Iseki M  et al. Muse Cells, Nontumorigenic Pluripotent-Like Stem Cells, Have Liver Regeneration Capacity Through Specific Homing and Cell Replacement in a Mouse Model of Liver Fibrosis. Cell Transplant 26:821-840 (2017). PubMed: 27938474
  • Wang H  et al. Establishment of patient-derived gastric cancer xenografts: a useful tool for preclinical evaluation of targeted therapies involving alterations in HER-2, MET and FGFR2 signaling pathways. BMC Cancer 17:191 (2017). PubMed: 28292264
  • Jia Y  et al. c-MET inhibition enhances the response of the colorectal cancer cells to irradiation in vitro and in vivo. Oncol Lett 11:2879-2885 (2016). WB ; Human . PubMed: 27073569
  • Kobayashi K  et al. The miR-199a/Brm/EGR1 axis is a determinant of anchorage-independent growth in epithelial tumor cell lines. Sci Rep 5:8428 (2015). IHC . PubMed: 25673149
  • Matsumoto Y  et al. A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: re-evaluation of EGFR gene status (NEJ006/TCOG0903). Lung Cancer 86:195-200 (2014). Human . PubMed: 25249428
  • Terwisscha van Scheltinga AG  et al. In vivo visualization of MET tumor expression and anticalin biodistribution with the MET-specific anticalin 89Zr-PRS-110 PET tracer. J Nucl Med 55:665-71 (2014). IHC ; Human . PubMed: 24614223
  • Ito Y  et al. Lung fibroblasts accelerate wound closure in human alveolar epithelial cells through hepatocyte growth factor/c-Met signaling. Am J Physiol Lung Cell Mol Physiol 307:L94-105 (2014). Human . PubMed: 24748602
  • Mitamura T  et al. Downregulation of miRNA-31 induces taxane resistance in ovarian cancer cells through increase of receptor tyrosine kinase MET. Oncogenesis 2:e40 (2013). IHC-P ; Human . PubMed: 23552883
  • Nicastro HL  et al. 3,3'-Diindolylmethane rapidly and selectively inhibits hepatocyte growth factor/c-Met signaling in breast cancer cells. J Nutr Biochem 24:1882-8 (2013). PubMed: 23968581
  • Hagman Z  et al. The tumour suppressor miR-34c targets MET in prostate cancer cells. Br J Cancer 109:1271-8 (2013). PubMed: 23922103
  • Jacobsen F  et al. High c-MET expression is frequent but not associated with early PSA recurrence in prostate cancer. Exp Ther Med 5:102-106 (2013). IHC-P ; Human . PubMed: 23251249
  • Tsai CH  et al. Timosaponin AIII Suppresses Hepatocyte Growth Factor-Induced Invasive Activity through Sustained ERK Activation in Breast Cancer MDA-MB-231 Cells. Evid Based Complement Alternat Med 2013:421051 (2013). PubMed: 23878598
  • Saigusa S  et al. Inhibition of HGF/cMET expression prevents distant recurrence of rectal cancer after preoperative chemoradiotherapy. Int J Oncol 40:583-91 (2012). PubMed: 21922134
  • Ohe M  et al. Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma. Diagn Pathol 7:3 (2012). IHC-P ; Human . PubMed: 22225786
  • Toiyama Y  et al. Co-expression of hepatocyte growth factor and c-Met predicts peritoneal dissemination established by autocrine hepatocyte growth factor/c-Met signaling in gastric cancer. Int J Cancer 130:2912-21 (2012). PubMed: 21796631
  • Kawamura M  et al. Correlation of MACC1 and MET expression in rectal cancer after neoadjuvant chemoradiotherapy. Anticancer Res 32:1527-31 (2012). IHC-P ; Human . PubMed: 22493396
  • Sakamoto K  et al. Pleomorphic phenotypes of gastrointestinal stromal tumors at metastatic sites with or without imatinib treatment. Cancer Sci 101:1270-8 (2010). PubMed: 20180814
  • Eaton CL  et al. Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer. Prostate 70:875-82 (2010). PubMed: 20127735
  • Ke AW  et al. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 49:491-503 (2009). WB, ICC/IF ; Human . PubMed: 19065669


Sign up